Skip to main content
SpringerLink
Log in

Heart Disease in the Child and Cardiogenic Shock

  • Chapter
Cardiogenic Shock

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 159 Accesses

Abstract

Heart diseases in infants and children can be classified as either congenital or acquired. The majority of congenital lesions are structural heart defects. Inborn errors of metabolism can produce heart disease that is also, technically, congenital. Acquired heart diseases can be subclassified into myocardial diseases (myocarditis, cardiomyopathy), valvular diseases (rheumatic fever, infective endocarditis), other inflammatory diseases such as Kawasaki’s disease, and arrhythmias (tachyarrhythmia and bradyarrhythmias).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rosenthal G. Prevalence of congenital heart disease. In: Garson A, Jr, Bricker JT, Fisher DJ, Neish SR, eds. The Science and Practice of Pediatric Cardiology. 2nd ed. Williams & Wilkins, Baltimore, MD, 1998, pp. 1625–1645.

    Google Scholar 

  2. Samanek M, Voriskova M. Congenital heart disease among 815,569 children born between 1980 and 1990 and their 15-year survival: a prospective Bohemia survival study. Pediatr Cardiol 1999; 20: 411–417.

    Article  PubMed  CAS  Google Scholar 

  3. Abu-Harb M, Hey E, Wern C. Death in infancy from unrecognized congenital heart disease. Arch Dis Child 1994; 71: 3–7.

    Article  PubMed  CAS  Google Scholar 

  4. Bower C, Ramsey JM. Congenital heart disease: a 10 year cohort. J Pediatr Child Health 1994; 30: 414–418.

    Article  CAS  Google Scholar 

  5. Ferencz C, Rubin JD, Loffredo CA, Magee C, eds. Perspectives in Pediatric Cardiology. Vol 4. Epidemiology of Congenital Heart Disease: The Baltimore-Washington Infant Study, 1981–1989. Futura, Mount Kisco NY, 1993.

    Google Scholar 

  6. Stark J, Gallivan S, Lovegrove J, et al. Mortality rates after surgery for congenital heart defects in children and surgeon’s performance. Lancet 2000; 355: 1004–1007.

    Article  PubMed  CAS  Google Scholar 

  7. Kern JH, Hayes CJ, Michler RE, Gersony WM, Quaegebeur JM. Survival and risk factor analysis for the Norwood procedure for hypoplastic left heart syndrome. Am J Cardiol 1997; 80: 170–174.

    Article  PubMed  CAS  Google Scholar 

  8. Hehrlein FW, Yamamoto T, Grime Y, Bauer J. Hypoplastic left heart syndrome: Which is the best operative strategy? Ann Thorac Cardiovasc Surg 1998; 4: 125–132.

    PubMed  CAS  Google Scholar 

  9. Richmond P, Harris L. Rheumatic fever in the Kimberely region of Western Australia. J Trop Pediatr 1998; 44: 148–152.

    Article  PubMed  CAS  Google Scholar 

  10. Bitar FF, Hayek P, Obeid M, Gharzeddine W, Mikati M, Dhaibo GS. Rheumatic fever in children: a 15-year experience in a developing country. Pediatr Cardiol 2000; 21: 119–122.

    Article  PubMed  CAS  Google Scholar 

  11. Yanagawa H, Nakamura Y, Sakatak K, Yashiro M. Use of intravenous gamma-globulin for Kawasaki disease: effect on cardiac sequelae. Pediatr Cardiol 1997; 18: 19–23.

    Article  PubMed  CAS  Google Scholar 

  12. Taubert KA, Rowley AH, Shulman ST. Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J 1994; 13: 704–708.

    Article  PubMed  CAS  Google Scholar 

  13. Fisher DJ. Perinatal maturation of the cardiomyocyte: An integrated view of the molecular basis of the perinatal maturation of cardiac function. In: Garson A Jr, Bricker JT, Fisher DJ, Neish SR, eds. The Science and Practice of Pediatric Cardiology. 2nd ed. Williams & Wilkins, Baltimore, MD, 1998, pp. 201–209.

    Google Scholar 

  14. Seguchi M, Harding JA, Jarmakani JM. Developmental changes in the function of sarcoplasmic reticulum. J Mol Cell Cardiol 1986; 18: 189–195.

    Article  PubMed  CAS  Google Scholar 

  15. Klitzner TS. Maturational changes in excitation-contraction coupling in mammalian myocardium. J Am Coll Cardiol 1991; 17: 218–225.

    Article  PubMed  CAS  Google Scholar 

  16. Epstein ML, Keil EA, Victoria BE. Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia. Pediatrics 1985; 75: 737–740.

    PubMed  CAS  Google Scholar 

  17. Mahony L, Jones LR. Developmental changes in cardiac sarcoplasmic reticulum calcium pump in sheep. J Biol Chem 1986;261:15, 257–15, 265.

    Google Scholar 

  18. Crepaz R, Pitscheider W, Radetti G, Gentili L. Age-related variation in left ventricular myocardial contractile state expressed by stress velocity relation. Pediatr Cardiol 1998; 19: 463–467.

    Article  PubMed  CAS  Google Scholar 

  19. Rowland DG, Gutgessel HP. Noninvasive assessment of myocardial contractility, perload and after-load in healthy newborn infants. Am J Cardiol 1995; 75: 818–821.

    Article  PubMed  CAS  Google Scholar 

  20. Holmgren SM, Goldberg SJ, Donnerstein RL. Influence of age, body size and heart rate on left ventricular diastolic indexes in young subjects. Am J Cardiol 1991; 68: 1245–1247.

    Article  PubMed  CAS  Google Scholar 

  21. Califf RM, Bengtson JR. Cardiogenic shock. N Eng J Med 1994; 330: 1724–1730.

    Article  CAS  Google Scholar 

  22. The American Heart Association in Collaboration with the International Liaison Committee on Resuscitation. Pediatric advanced life support. Guidelines of the American Heart Association. Circulation 2000;102(Suppl I):I-291-I-342.

    Google Scholar 

  23. Tobin JR, Wetzel RC. Shock and multiorgan failure. In: Rogers MC, Nichols DG, eds. Texbook of Pediatric Intensive Care. Williams & Wilkins, Baltimore, MD, 1996, pp. 555–605.

    Google Scholar 

  24. McMurphy DM, Heyman MA, Rudolph AM, Melmin KL. Developmental changes in constriction of the ductus arteriosus: response to oxygen and vasoactive substances in the isolated ductus arteriosus of the fetal lamb. Pediatr Res 1972; 6: 231–238.

    Article  PubMed  CAS  Google Scholar 

  25. Albert DA, Harel L, Karrison T. The treatment of rheumatic carditis: a review and meta-analysis. Medicine Baltimore 1995; 74: 1–12.

    Article  PubMed  CAS  Google Scholar 

  26. Booker PD, Evans C, Franks R. Comparison of the haemodynamic effects of dopamine and dobutamine in young children undergoing cardiac surgery. Br J Anaesth 1995; 74: 419–423.

    Article  PubMed  CAS  Google Scholar 

  27. Greenough A, Emery EF. Randomized trial comparing dopamine and dobutamine in preterm infants. Eur J Pediatr 1993; 152: 925–927.

    Article  PubMed  CAS  Google Scholar 

  28. Chang AC, Atz AM, Wernovsky G, Burke RP, Wessel DL. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 1995; 23: 1907–1914.

    Article  PubMed  CAS  Google Scholar 

  29. Haydar A, Mauriat P, Pouard P, et al. Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects. Lancet 1992; 340: 1545.

    Article  PubMed  CAS  Google Scholar 

  30. Jonmaker C, Olsson AK, Jogi P, Forsell C. Hemodynamic effects of tracheal and intravenous adrenaline in infants with congenital heart disease. Acta Anaesthesiol Scand 1996; 99: 65–72.

    Google Scholar 

  31. Appelbaum A, Blackstone EH, Kouchoukos NT, Kirklin JW. Afterload reduction and cardiac output in infants after intracardiac surgery. Am J Cardiol 1977; 39: 445–451.

    Article  PubMed  CAS  Google Scholar 

  32. Seri I, Rudas G, Bors Z, Kanycska B, Tulassay T. Effect of low-dose dopamine infusion on cardiovascular and renal functions, cerebral blood flow, and plasma catecholamine levels in sick preterm neonates. Pediatr Res 1993; 34: 742–749.

    Article  PubMed  CAS  Google Scholar 

  33. Seri I. Cardiovascular, renal, and endocrine actions of dopamine in neonates and children. J Pediatr 1995; 126: 333–344.

    Article  PubMed  CAS  Google Scholar 

  34. Lass NA, Glock D, Goldberg LI. Cardiovascular and renal hemodynamic effects of intravenous infusion of the selective DA1 agonist, fenoldopan, used alone or in combination with dopamine and dobutamine. Circulation 1988; 78: 1310–1315.

    Article  PubMed  CAS  Google Scholar 

  35. Tuttle RR, Mills J. Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res 1975; 36: 185–196.

    Article  PubMed  CAS  Google Scholar 

  36. Perkin RM, Levin DL, Webb R, Aquino A, Reedy J. Dobutamine: a hemodynamic evaluation in children with shock. J Pediatr 1982; 100: 977–983.

    Article  PubMed  CAS  Google Scholar 

  37. Barton P, Garcia J, Kouatli A, et al. Hemodynamic effects of iv milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. Chest 1996; 109: 1302–1312.

    Article  PubMed  CAS  Google Scholar 

  38. Worthley LI, Tyler P, Moran JL. A comparison of dopamine, dobutamine and isoproterenol in the treatment of shock. Intensive Care Med 1985; 11: 13–19.

    PubMed  CAS  Google Scholar 

  39. Cotter G, Kaluski E, Blatt A, et al. L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock. Circulation 2000; 101: 1358–1361.

    Article  PubMed  CAS  Google Scholar 

  40. Moulopoulos S, Topaz S, Lolff W. Diastolic balloon pumping (with carbon dioxide) in the aorta-a mechanical assistance to the failing heart. Circulation 1962; 63: 669–675.

    CAS  Google Scholar 

  41. Meyns B, Sergeant P, Wouters P, et al. Mechanical support with microaxial blood pumps for postcardiotomy left ventricular failure: can outcome be predicted? J Thorac Cardiovasc Surg 2000; 120: 393–400.

    Article  PubMed  CAS  Google Scholar 

  42. Anderson H, Attorri R, Custer J, Chapman R, Bartlett R. Extracorporeal membrane oxygenation for pediatric cardiopulmonary failure. J Thorac Cardiovasc Surg 1990; 99: 1011–1012.

    PubMed  Google Scholar 

  43. Klein M, Shahedn K, Whittlesey G, Pinsky W, Arciniegas E. Extracorporeal membrane oxygenation for the circulatory support of children after repair of congenital heart disease. J Thorac Cardiovasc Surg 1990; 100: 498–507.

    PubMed  CAS  Google Scholar 

  44. Kanter K, Pennington G, Weber T, Zambie M, Braun P, Martychenko V. Extracorporeal membrane oxygenation for postoperative cardiac support in children. J Thorac Cardiovasc Surg 1987; 93: 27–35.

    PubMed  CAS  Google Scholar 

  45. Rogers A, Trento A, Siewers R, et al. Extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock in children. Ann Thorac Surg 1989; 47: 903–906.

    Article  PubMed  CAS  Google Scholar 

  46. Raithel S, Pennington G, Boegner E, Fiore A, Weber T. Extracorporeal membrane oxygenation in children after cardiac surgery. Circulation 1992;86:(Suppl II):II-305-II-310.

    Google Scholar 

  47. Weinhaus L, Canter C, Noetzel M, McAlister W, Spray T. Extracorporeal membrane oxygenation for circulatory support after repair of congenital heart defects. Ann Thorac Surg 1989; 48: 206–212.

    Article  PubMed  CAS  Google Scholar 

  48. Ibrahim AE, Duncan BW, Blume ED, Jonas RA. Long-term follow-up of pediatric cardiac patients requiring mechanical circulatory support. Ann Thorac Surg 2000; 69: 189–192.

    Article  Google Scholar 

  49. Park J, Hsu D, Gersony W. Intraaortic balloon pump management of refractory congestive heart failure in children. Pediatr Cardiol 1993; 14: 19–22.

    PubMed  CAS  Google Scholar 

  50. Veasy L, Blalock R, Orth J, Boucek M. Intra-aortic balloon pumping in infants and children. Circulation 1983; 68: 1095–1100.

    Article  PubMed  CAS  Google Scholar 

  51. Pollock J, Charlton M, Williams W, Edmonds J, Truster G. Intraaortic balloon pumping in children. Ann Thorac Surg 1980; 29: 522–528.

    Article  PubMed  Google Scholar 

  52. Webster H, Veasy L. Intra-aortic balloon pumping in children. Heart Lung 1985; 14: 548–555.

    PubMed  CAS  Google Scholar 

  53. Karl T, Horton S. Options for mechanical support in pediatric patients. In: Goldstein D, Oz M, eds. Cardiac Assist Devices. Futura, Armonk, NY, 2000, pp. 37–62.

    Google Scholar 

  54. Karl T, Sano S, Horton S, Mee R. Centrifugal pump left heart assisted pediatric cardiac operations: Indications, techniques, and results. J Thorac Cardiovasc Surg 1991; 102: 624–630.

    PubMed  CAS  Google Scholar 

  55. Farrar D, Lawson J, Litwak P, Cederwall G. Thoratec VAD system as a bridge to heart transplantation. J Heart Transplant 1990; 9: 415–423.

    PubMed  CAS  Google Scholar 

  56. Joyce L, Johnson K, Toninato C, et al. Results of the first 100 patients who received Symbion total artificial hearts as a bridge to cardiac transplantation. Circulation 1989;80(Suppl III):III192-III-201.

    Google Scholar 

  57. Mehta S, Aufiero T, Pae W, Miller C, Pierce W. Combined Registry for the Clinical Use of Mechanical Ventricular Assistance Pumps and the Total Artifical Heart in Conjunction with Heart Transplantation: Sixth Official Report-1994. J Heart Lung Transplant 1995; 14: 585–593.

    PubMed  CAS  Google Scholar 

  58. Frazier, O., Nakatani, T., Duncan, M., Parnis, S., Fuqua, J. Clinical experience with the Hemopump. Trans Am Soc Artif Intern Organs 1989; 35: 604–606.

    Article  CAS  Google Scholar 

  59. Artman M, Boucek RJ Jr, Hammon J Graham TP Jr. Emergency palliation of critical valvar aortic stenosis. Am J Dis Child 1983; 137: 339–340.

    PubMed  CAS  Google Scholar 

  60. Howkins JA, Michin LL, Tani LY, et al. Late results and reintervention after aortic valvotomy for critical aortic stenosis in neonates and infants. Ann Thorac Surg 1998; 65: 1758–1763.

    Article  Google Scholar 

  61. Alexiou C, Langley M, Dalrymple-Hay MJR, et al. Open commissurotomy for critical isolated aortic stenosis in neonates. Ann Thorac Surg 2001; 71: 489–493.

    Article  PubMed  CAS  Google Scholar 

  62. Lababidi Z, Weinhous L. Successful balloon valvuloplasty for neonatal critical aortic stenosis. Am Heart J 1986; 12: 913–916.

    Article  Google Scholar 

  63. Egito EST, Moore P, O’Sullivan T, Colan S, Perry SB, Lock JE. Transvascular balloon dilatation for neonatal aortic stenosis: early and midterm results. J Am Coll Cardiol 1997; 29: 442–447.

    Article  PubMed  CAS  Google Scholar 

  64. Weber HS, Mart CR, Kupferschmid J, Myers JL, Cyran SE. Transcarotid balloon valvuloplasty with continuous transesophageal echocardiographic guidance for neonatal critical aortic valve stenosis: An alternative to surgical palliation. Pediatr Cardiol 1998; 19: 212–217.

    Article  PubMed  CAS  Google Scholar 

  65. Maeno M, Akagi T, Hashino M, et al. Carotid artery approach to balloon aortic valvuloplasty in infants with critical aortic valve stenosis. Ped Cardiol 1997; 18: 288–291.

    Article  CAS  Google Scholar 

  66. Kohl T, Sharland G, Allan LD, et al. World experience of percutaneous ultrasound-guided balloon valvuloplasty in human fetuses with severe aortic valve obstruction. Am J Cardiol 2000; 85: 1230–1233.

    Article  PubMed  CAS  Google Scholar 

  67. Barber G. Hypoplastic left heart syndrome. In: Garson A Jr, Bricker JT, Fisher DJ, Neish, SR, eds. The Science and Practice of Pediatric Cardiology. 2nd ed. Williams & Wilkins, Baltimore, MD, 1998, pp. 1625–1645.

    Google Scholar 

  68. Hehrlein FW, Yamamoto T, Orime Y, Bauer J. Hypoplastic left heart syndrome: which is the best operative strategy? Ann Thorac Cardiovasc Surg 1998; 4: 125–132.

    PubMed  CAS  Google Scholar 

  69. Kern JH, Hayes CJ, Michler RE, Gersony WM, Quaegebeur JM. Survival and risk factor analysis for the Norwood procedure for hypoplastic left heart syndrome. Am J Cardiol 1997; 80: 170–174.

    Article  PubMed  CAS  Google Scholar 

  70. Williams DL, Gelijns AC, Moskowitz AJ, et al. Hypoplastic left heart syndrome: valuing the survival. J Thorac Cardiovasc Surg 2000; 119: 720–731.

    Article  PubMed  CAS  Google Scholar 

  71. Jenkins PC, Flanagan MF, Jenkins KJ, et al. Survival analysis and risk factors for mortality in transplantation and staged surgery for hypoplastic left heart syndrome. J Am Coll Cardiol 2000; 36: 1178–1185.

    Article  PubMed  CAS  Google Scholar 

  72. Cohen DM, Allen HD. New developments in the treatment of hypoplastic left heart syndrome. Curr Opin Cardiol 1997; 12: 44–50.

    Article  PubMed  CAS  Google Scholar 

  73. Mahle WT, Clancy RR, Moss EM, Gerdes M, Jobes DR, Wernovsky G. Neurodevelopmental outcome and lifestyle assessment in school-aged and adolescent children with hypoplastic left heart syndrome. Pediatrics 2000; 105: 1082–1089.

    Article  PubMed  CAS  Google Scholar 

  74. Fletcher SE, Nihill MR, Grifka RG, O’Laughlin MP, Mullins CE. Balloon angioplasty of native coarctation of the aorta: midterm follow-up and prognostic factors. J Am Coll Cardiol 1995; 25: 730–734.

    Article  PubMed  CAS  Google Scholar 

  75. Kain SF, Smith EO, Mott AR, Mullins CE, Geva T. Quantitative echocardiographic analysis of the aortic arch outcome of balloon angioplasty of native coarctation of the aorta. Circulation 1996; 94: 1056–1062.

    Article  Google Scholar 

  76. Quaegebeeur JM, Jonas RA, Weinberg AD, Blackstone EH, Kirklin JW, and the Congenital Heart Surgeons’ Society. Outcome of seriously ill neonates with coarctation of the aorta. A multiinstitutional study. J Thorac Cardiovasc Surg 1994; 108: 841–854.

    Google Scholar 

  77. Gournay V, Piechaud JF, Delogu A, Sidi D, Kachaner J. Balloon valvotomy for critical stenosis or atresia of pulmonary valve in newborns. J Am Coll Cardiol 1995; 26: 1725–1731.

    Article  PubMed  CAS  Google Scholar 

  78. Wang JK, Wu MH, Lee WL, Cheng CF, Lue HC. Balloon dilatation for critical pulmonary stenosis. Int J Cardiol 1999; 69: 27–32.

    Article  PubMed  CAS  Google Scholar 

  79. Ward KE, Mullins CE. Anomalous pulmonary venous connections, pulmonary vein stenosis, and atresia of the common pulmonary vein. In: Garson A, Jr, Bricker JT, Fisher DJ, Neish SR, eds. The Science and Practice of Pediatric Cardiology. 2nd ed, Williams & Wilkins, Baltimore, MD, 1998, Vol. 1, pp. 1431–1461.

    Google Scholar 

  80. Duff DF, Nihill MR, McNamara DG. Infradiaphragmatic total anomalous pulmonary venous return: review of clinical and pathological findings and results of operation in 28 cases. Br Heart J 1977; 39: 619–626.

    Article  PubMed  CAS  Google Scholar 

  81. Okamoto K, Sato T, Kurose M, Kukita I, Fujii H, Taki K. Successful use of inhaled nitric oxide for treatment of severe hypoxemia in an infant with total anomalous pulmonary venous return. Anesthesiology 1994; 81: 256–259.

    Article  PubMed  CAS  Google Scholar 

  82. Atz AM, Wessel DL. Inhaled nitric oxide in neonates with cardiac disease. Semin Perinatol 1997; 21: 441–455.

    Article  PubMed  CAS  Google Scholar 

  83. Bullaboy CA, Johonson DH, Azar H, Jennings RB Jr. Total anomalous pulmonary venous connection to portal system: a new therapeutic role for prostaglandin El? Pediatr Cardiol 1984; 5: 115–116.

    Article  PubMed  CAS  Google Scholar 

  84. Vouhe PR, Baillot-Vernant F, Trinquet F, et al. Anomalous left coronary artery from the pulmonary artery in infants. J Thorac Cardiovasc Surg 1987; 94: 192–199.

    PubMed  CAS  Google Scholar 

  85. Takeuchi S, Imamura H, Katsumoto K, et al. New surgical method for repair of anomalous left coronary artery from pulmonary artery. J Thorac Cardiovasc Surg 1979; 78: 7–11.

    PubMed  CAS  Google Scholar 

  86. Chang AC, Hanely FL. Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA). In: Chang AC, Hanely FL, Wernovsky G, Wessel DL, eds. Pediatric Cardiac Intensive Care. Lippincott Williams & Wilkins, Philadelphia, 1998: 312–316.

    Google Scholar 

  87. Turley K, Szamicki RJ, Flachsbart KD, Richter RC, Popper RW, Tarnoff H. Aortic implantation is possible in all cases of anomalous origin of the left coronary artery from the pulmonary artery. Ann Thorac Surg 1995; 60: 84–89.

    PubMed  CAS  Google Scholar 

  88. Hsieh YY, Lee CC, Chang CC, Tsai HD, Yeh LS, Tsai CH. Successful prenatal digoxin therapy for Ebstein anomaly with hydrops fetalis. A case report. J Reproduct Med 1998; 4: 710–712.

    Google Scholar 

  89. Yetman AT, Freedom RM, McCrindle BW. Outcome of cyanotic neonates with Ebstein’s anomaly. Am J Cardiol 1998; 81: 749–754.

    Article  PubMed  CAS  Google Scholar 

  90. Bruckheimer E, Bulbul Z, Pinter E, Gailani M, Kleinman CS, Fahey JT. Inhaled nitric oxide therapy in a critically ill neonate with Ebstein’s anomaly. Pediatr Cardiol 1998; 19: 477–479.

    Article  PubMed  CAS  Google Scholar 

  91. Roberson DA, Silverman NH. Ebstein anomaly: echocardiographic and clinical features in the fetus, and neonate. J Am Coll Cardiol 1989; 14: 1300–1307.

    Article  PubMed  CAS  Google Scholar 

  92. Chang AC, Hanely FL, Ebstein anomaly of the tricuspid valve. In: Chang AC, Hanely FL, Wernovsky G, Wesse DL, eds. Pediatric Cardiac Intensive Care. Lippincott Williams & Wilkins, Philadelphia, 1998, pp. 316–321.

    Google Scholar 

  93. Augustin N, Schmidt-Habelmann P, Wottke M, Meisner H, Sebening F. Results after surgical repair of Ebstein’s anomaly. Ann Thorac Surg 1997; 63: 1650–1656.

    Article  PubMed  CAS  Google Scholar 

  94. Knott-Craig CJ, Overholt ED, Ward KE, Razook JD. Neonatal repair of Ebstein’s anomaly: indications, surgical technique, and medium-term follow-up. Ann Thorac Surg 2000; 69: 1505–1510.

    Article  PubMed  CAS  Google Scholar 

  95. Celermajer DS, Bull C, Till JA, et al. Ebstein anomaly: presentation and outcome from fetus to adult. J Am Coll Cardiol 1994; 23: 170–176.

    Article  PubMed  CAS  Google Scholar 

  96. Camargo PR, Snitcowsky R, Da Luz PL, et al. Favorable effect of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol 1995; 16: 61–68.

    Article  PubMed  CAS  Google Scholar 

  97. Pophal SG, Sigfusson G, Booth KL, et al. Complications of endomyocardial biopsy in children. J Am Coll Cardiol 1999; 34: 2105–2110.

    Article  PubMed  CAS  Google Scholar 

  98. Akhtar N, Stomberg D, Rosenthal GL, Bowles NE, Towbin JA. Tracheal aspirate as a substrate for polymerase chain reaction detection of viral genome in childhood pneumonia and myocarditis. Circulation 1999; 99: 2011–2018.

    Article  PubMed  CAS  Google Scholar 

  99. Taliercio CP, Seward JB, Driscoll DJ, Fisher LD, Gersh BJ, Tajik AJ. Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. J Am Coll Cardiol 1985; 6: 1126–1131.

    Article  PubMed  CAS  Google Scholar 

  100. Wiles HB, Gillette PC, Harley RA, Upshur JK. Cardiomyopathy and myocarditis in children with ventricular ectopic rhythm. J Am Coll Cardiol 1992; 20: 359–362.

    Article  PubMed  CAS  Google Scholar 

  101. Leatherbury L, Chandra RS, Shapiro SR, Perry LW. Value of endomyocardial biopsy in infants, children and adolescents with dilated cardiomyopathy and myocarditis. J Am Coll Cardiol 1988; 12: 1547–1554.

    Article  PubMed  CAS  Google Scholar 

  102. Chen RT, Broome CV, Weinstein RA, Weaver R. Diphtheria in the United States, 1971–1998 Am J Public Health 1985; 75: 1393–1397.

    CAS  Google Scholar 

  103. Kadirova R, Kartoglu HU, Strebel PM. Clinical characteristics and management of 676 hospitalized diphtheria cases, Kyrgyz republic, 1995. J Infect Dis 2000;Suppl:S 110-S115.

    Google Scholar 

  104. Perles Z, Nir A, Cohen E, Bashary A, Engelhard D. Atrio-ventricular block in a toxic child. Do not forget the diphtheria. Pediatr Cardiol 2000; 21: 282–283.

    Article  PubMed  CAS  Google Scholar 

  105. Drucker NA, Colan SD, Lewis AB, et al. Gamma-globulin treatment of acute myocarditis in pediatric population. Circulation 1994; 89: 252–257.

    Article  PubMed  CAS  Google Scholar 

  106. Mason JW, O’Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995; 333: 269–275.

    Article  PubMed  CAS  Google Scholar 

  107. Zales VR, Deal BJ, Pahl E, Wright KL, Alboliras ET, Crawford S. High-dose steroids therapy for acute myocarditis in pediatric patients. Circulation 1994; 90: I - 50.

    Google Scholar 

  108. Lee KJ, McCrindle BW, Bohn DJ, et al. Clinical outcome of acute myocarditis in childhood. Heart 1999; 82: 226–233.

    PubMed  CAS  Google Scholar 

  109. McCarthy RE, Boehmer JP, Hutchins GM, Kasper EK, Hare JM, Baughman KL. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000; 342: 690–695.

    Article  PubMed  Google Scholar 

  110. Felix SB, Staudt A, Dorffel WV, et al. Hemodynamic effect of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy. J Am Coll Cardiol 2000; 35: 1590–1598.

    Article  PubMed  CAS  Google Scholar 

  111. Pepine C.J. The therapeutic potential of carnitine in cardiovascular disorders. Clin Ther 1991; 13: 2–21.

    PubMed  CAS  Google Scholar 

  112. Winter SC, Szabo-Aczel S, Curry CJR, Hutchinson HT, Hogue R, Shung A. Plasma carnitine deficiency. Am J Dis Child 1987; 141: 660–665.

    PubMed  CAS  Google Scholar 

  113. Ino T, Sherwood WG, Benson LN, Wilson GJ, Freedom RM, Rowe RD. Cardiac manifestations of disorders of fat and carnitine metabolism in infancy. J Am Coll Cardiol 1988; 11: 1301–1308.

    Article  PubMed  CAS  Google Scholar 

  114. Lewis AB. The failing myocardium. In: Chang AC, Hanely FL, Wernovsky G, Wesse DL, eds. Pediatric Cardiac Intensive Care. Lippincott Williams & Wilkins, Philadelphia, 1998, pp. 483–496.

    Google Scholar 

  115. Wexler LH. Ameliorating anthracycline cardiotoxicity in children with cancer: clinical trials with dexrazoxane. Semin Oncol 1998; 25 (Suppl 10): 86–92.

    PubMed  CAS  Google Scholar 

  116. Grenier MA, Lipshultz SE. Epidemiology of anthracycline cardiotoxicity in children and adults. Semin Oncol 1998; 25 (Suppl 10): 72–85.

    PubMed  CAS  Google Scholar 

  117. Laupland KB, Davis HD. Epidemiology, etiology, and management of Kawasaki disease: state of the art. Pediatr Cardiol 1999; 20: 177–183.

    Article  PubMed  CAS  Google Scholar 

  118. Dajani AS, Taubert KA, Takahashi M, et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation 1994; 89: 916–922.

    Article  PubMed  CAS  Google Scholar 

  119. Durongpisitkul K, Guruaj VJ, Park JM, Martin CH. The prevention of coronary artery aneurysm in Kawasaki Disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 1995; 96: 1057–1061.

    PubMed  CAS  Google Scholar 

  120. Kim M, Kim K. Elevation of cardiac troponin I in the acute stage of Kawasaki disease. Pediatr Cardiol 1999; 20: 184–188.

    Article  PubMed  CAS  Google Scholar 

  121. Kawamura T, Wago M, Kawaguchi H, Tahara M, Yuge M. Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Cardiol 2000; 42: 241–248.

    CAS  Google Scholar 

  122. Fukazawa M, Fukushige J, Takeuchi T, et al. Discordance between thallium-201 scintigraphy and coronary angiography in patients with Kawasaki’s disease: myocardial ischemia with normal coronary angiogram. Pediatr Cardiol 1993; 14: 67–74.

    Article  PubMed  CAS  Google Scholar 

  123. Kato H, Ichinnose E, Kawasaki T. Myocardial infarction in Kawasaki disease: clinical analysis in 195 cases. J Pediatr 1986; 108: 923–927.

    Article  PubMed  CAS  Google Scholar 

  124. Yanagawa H, Nakamura Y, Sakata K, Yashiro M. Use of intravenous gamma-globulin for Kawasaki disease: effect on cardiac sequelae. Pediatr Cardiol 1997; 18: 19–23.

    Article  PubMed  CAS  Google Scholar 

  125. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of Kawasaki syndrome. N Engl J Med 1991; 324: 1633–1639.

    Article  PubMed  CAS  Google Scholar 

  126. Dale RC, Saleem, Daw S, Dillon MJ. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. J Pediatr 2000; 137: 723–726.

    Article  PubMed  CAS  Google Scholar 

  127. Johnsrude CL, Towbin JA. Myocardial infarction in childhood. In: Garson A, Jr, Bricker JT, Fisher DJ, Neish, SR, eds, The Science and Practice of Pediatric Cardiology. 2nd ed. Williams & Wilkins, Baltimore, MD, 1998, pp. 1933–1982.

    Google Scholar 

  128. Akaji T, Ogawa S, Ino T, et al. Catheter interventional treatment in Kawasaki disease: a report from the Japanese pediatric interventional cardiology investigation group. J Pediatr 2000; 137: 181–186.

    Article  Google Scholar 

  129. Kitamura S, Kameda Y, Seki T, et al. Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study. J Thorac Cardiovasc Surg 1994; 107: 663–673.

    PubMed  CAS  Google Scholar 

  130. Catanzaro FT, Stenson CA, Morris AJ, et al. The role of the streptococcus in the pathogenesis of rheumatic fever. Am J Med 1954; 17: 749–756.

    Article  PubMed  CAS  Google Scholar 

  131. Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. Circulation 1985; 72: 1155–1162.

    Article  PubMed  CAS  Google Scholar 

  132. Dajani AS, Ayub E, et al. The special writing group of the committee on rheumatic fever, endocarditis, and Kawasaki disease of the council on cardiovascular disease in the young of the American Heart Association. Guidelines for the diagnosis of rheumatic fever. JAMA 1992; 268: 2069–2073.

    Article  Google Scholar 

  133. Veasy LG, Wiedmeier SE, Orsmond GS, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 1987; 316: 421–427.

    Article  PubMed  CAS  Google Scholar 

  134. Karaaslan S, Oran B, Reisli I, Erkul I. Acute rheumatic fever in Konya, Turkey. Pediatr Int 2000; 42: 71–75.

    Article  PubMed  CAS  Google Scholar 

  135. Albert DA, Harel L, Karrison T. The treatment of rheumatic carditis: a review and meta-analysis. Medicine (Baltimore) 1995; 74: 1–12.

    Article  CAS  Google Scholar 

  136. Human DG, Hill ID, Fraser CB. Treatment choice in acute rheumatic fever. Arch Dis Child 1984; 59: 410–413.

    Article  PubMed  CAS  Google Scholar 

  137. Roth SJ. Postoperative care. In: Chang AC, Hanely FL, Wernovsky G, Wessel DL, eds: Pediatric Cardiac Intensive Care. Lippincott Williams & Wilkins, Philadelphia, 1998, pp. 163–187.

    Google Scholar 

  138. Haydar A, Mauriat P, Pouard P, et al. Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects. Lancet 1992; 340: 1545.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Amiram Nir MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Azaria J. J. T. Rein MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David J. Driscoll MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Tel-Aviv University, Tel Aviv, Israel

    David Hasdai MD  & Alexander Battler MD  & 

  2. Department of Cardiology, Rabin Medical Center, Petah-Tikva, Israel

    Alexander Battler MD

  3. Internal Medicine and Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA

    Peter B. Berger MD  & David R. Holmes Jr. MD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Nir, A., Rein, A.J.J.T., Driscoll, D.J. (2002). Heart Disease in the Child and Cardiogenic Shock. In: Hasdai, D., Berger, P.B., Battler, A., Holmes, D.R. (eds) Cardiogenic Shock. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-154-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-154-1_16

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-312-1

  • Online ISBN: 978-1-59259-154-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation